JP2013523814A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2013523814A5 JP2013523814A5 JP2013503806A JP2013503806A JP2013523814A5 JP 2013523814 A5 JP2013523814 A5 JP 2013523814A5 JP 2013503806 A JP2013503806 A JP 2013503806A JP 2013503806 A JP2013503806 A JP 2013503806A JP 2013523814 A5 JP2013523814 A5 JP 2013523814A5
- Authority
- JP
- Japan
- Prior art keywords
- alkyl
- halo
- substituted
- mono
- het
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US32199210P | 2010-04-08 | 2010-04-08 | |
| US61/321,992 | 2010-04-08 | ||
| PCT/US2011/031040 WO2011126960A1 (en) | 2010-04-08 | 2011-04-04 | Oxazole derivatives useful as modulators of faah |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2013523814A JP2013523814A (ja) | 2013-06-17 |
| JP2013523814A5 true JP2013523814A5 (enExample) | 2014-05-22 |
Family
ID=44763231
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2013503806A Pending JP2013523814A (ja) | 2010-04-08 | 2011-04-04 | Ｆａａｈの調節薬として有用なオキサゾール誘導体 |
Country Status (8)
| Country | Link |
|---|---|
| US (1) | US9193697B2 (enExample) |
| EP (1) | EP2555772B1 (enExample) |
| JP (1) | JP2013523814A (enExample) |
| CN (1) | CN102917704A (enExample) |
| AU (1) | AU2011238487B2 (enExample) |
| BR (1) | BR112012023974A2 (enExample) |
| CA (1) | CA2793900A1 (enExample) |
| WO (1) | WO2011126960A1 (enExample) |
Families Citing this family (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP5698666B2 (ja) * | 2008-08-04 | 2015-04-08 | メルク・シャープ・アンド・ドーム・コーポレーションＭｅｒｃｋ Ｓｈａｒｐ ＆ Ｄｏｈｍｅ Ｃｏｒｐ． | Ｆａａｈの阻害剤として有用なオキサゾール誘導体 |
| US9006433B2 (en) | 2010-04-21 | 2015-04-14 | Merck Sharp & Dohme Corp. | Substituted pyrimidines |
| BR112019016241A2 (pt) | 2017-02-08 | 2020-04-07 | Bayer Cropscience Ag | derivados de triazol e seu uso como fungicidas |
| CA3052519A1 (en) | 2017-02-08 | 2018-08-16 | Andreas Gortz | Triazolethione derivatives |
| US20200045967A1 (en) | 2017-02-08 | 2020-02-13 | Bayer Cropscience Aktiengesellschaft | Novel triazole derivatives |
| KR20190115449A (ko) | 2017-02-10 | 2019-10-11 | 바이엘 악티엔게젤샤프트 | 1-(페녹시-피리디닐)-2-(1,2,4-트리아졸-1-일)-에탄올 유도체를 포함하는 유해 미생물을 방제하기 위한 조성물 |
| IL271149B2 (en) * | 2017-06-14 | 2024-05-01 | Trevena Inc | Compounds for modulating s1p1 activity and methods of using the same |
| WO2020020816A1 (en) | 2018-07-26 | 2020-01-30 | Bayer Aktiengesellschaft | Novel triazole derivatives |
| CN110804048A (zh) * | 2019-11-08 | 2020-02-18 | 暨南大学 | 恶唑酮类化合物及其应用、faah的正电子药物 |
| WO2021101854A1 (en) | 2019-11-19 | 2021-05-27 | Trevena, Inc. | Compounds and methods of preparing compounds s1p1 modulators |
| KR20250033421A (ko) * | 2023-08-29 | 2025-03-10 | 인천대학교 산학협력단 | 옥사졸 유사체를 유효성분으로 포함하는 항노화 조성물 |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2007140005A2 (en) * | 2006-05-26 | 2007-12-06 | Janssen Pharmaceutica N.V. | Oxazolyl piperidine modulators of fatty acid amide hydrolase |
| FR2921063B1 (fr) | 2007-09-13 | 2009-12-11 | Sod Conseils Rech Applic | Ligands des recepteurs cannabinoides |
| CA2727245A1 (en) * | 2008-06-11 | 2009-12-17 | Merck Sharp & Dohme Corp. | Imidazole derivatives useful as inhibitors of faah |
| JP5698666B2 (ja) * | 2008-08-04 | 2015-04-08 | メルク・シャープ・アンド・ドーム・コーポレーションＭｅｒｃｋ Ｓｈａｒｐ ＆ Ｄｏｈｍｅ Ｃｏｒｐ． | Ｆａａｈの阻害剤として有用なオキサゾール誘導体 |
| EP2528603A4 (en) * | 2010-01-28 | 2013-09-04 | Merck Sharp & Dohme | PHARMACEUTICAL COMPOSITIONS FOR TREATING PAIN AND OTHER DISPLAYS |
-
2011
- 2011-04-04 WO PCT/US2011/031040 patent/WO2011126960A1/en not_active Ceased
- 2011-04-04 AU AU2011238487A patent/AU2011238487B2/en not_active Ceased
- 2011-04-04 JP JP2013503806A patent/JP2013523814A/ja active Pending
- 2011-04-04 CA CA2793900A patent/CA2793900A1/en not_active Abandoned
- 2011-04-04 BR BR112012023974A patent/BR112012023974A2/pt not_active IP Right Cessation
- 2011-04-04 US US13/635,303 patent/US9193697B2/en active Active
- 2011-04-04 CN CN2011800173842A patent/CN102917704A/zh active Pending
- 2011-04-04 EP EP11766539.8A patent/EP2555772B1/en active Active
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2013523814A5 (enExample) | ||
| JP2013525356A5 (enExample) | ||
| AU2018358160B2 (en) | Modulators of the integrated stress pathway | |
| JP2016516043A5 (enExample) | ||
| KR20190041471A (ko) | 케모카인 수용체 조절제 및 이의 용도 | |
| SI3018132T1 (en) | Condensed imidazole derivatives useful as IDO inhibitors | |
| JP2016525076A5 (enExample) | ||
| JP6529492B2 (ja) | 癌の処置のためのｉｄｈ２突然変異体阻害剤としての２，４−または４，６−ジアミノピリミジン化合物 | |
| JP2019533694A5 (enExample) | ||
| JP2015524472A5 (enExample) | ||
| ES2910071T3 (es) | Compuestos de aminopirazina diol como inhibidores de PI3K-Y | |
| JP2013528204A5 (enExample) | ||
| US20200361881A1 (en) | Modulators of the integrated stress pathway | |
| JP2015535277A5 (enExample) | ||
| EA032609B1 (ru) | Соединения аминопиримидинила в качестве ингибиторов jak | |
| JP2011500806A5 (enExample) | ||
| JP2016522232A5 (enExample) | ||
| EA028122B1 (ru) | 3-пиримидин-4-илоксазолидин-2-оны в качестве ингибиторов мутантного idh | |
| PH12014501561B1 (en) | Therapeutically active compounds and their methods of use | |
| JP2016525075A5 (enExample) | ||
| JP2014528464A5 (enExample) | ||
| RU2017118165A (ru) | Ингибиторы энхансера гомолога 2 zestes | |
| RU2015101102A (ru) | Гетероароматическое метильное производное циклического амина | |
| JP2014510147A5 (enExample) | ||
| RU2014103587A (ru) | Производные циклических аминов в качестве антагонистов рецептора ер4 |